Pre-market Hot Trades in US Stocks

SharpLink Gaming is up 6.94% in pre-market trading. Based on recent important news:

1. On July 8, SharpLink Gaming announced the purchase of 7,689 ETH, bringing its total holdings to 205,634 ETH, which drove the stock price up by 26%.

2. On July 8, the company rang the bell on Nasdaq to celebrate its Ethereum treasury strategy, resulting in significant stock price fluctuations.

3. On July 9, SharpLink Gaming continued to increase its Ethereum holdings, further boosting the stock price.

Top Gainers in Pre-market US Stocks

Sobr Safe is up 60.24% in pre-market trading. Based on recent important news:

1. On June 23, WuXi AppTec-B debuted, opening at 21.65 yuan, up 64.6% from the listing price of 13.15 yuan, with the market optimistic about the new stock's performance, driving related sectors up.

2. On June 26, WuXi AppTec-B surged nearly 5% in the closing hours, doubling from the offering price, indicating market confidence in its future growth.

3. On June 20, the Futu trading platform showed WuXi AppTec-B opening high at 21.8% in the dark market, with strong market expectations driving the stock price significantly higher.

Calidi Biotherapeutics is up 56.78% in pre-market trading. Based on recent key news:

1. On January 19, news that Anhui would lead the national biopharmaceutical alliance procurement caused stock prices of several innovative drug companies to drop, with Innovent Biologics experiencing the largest decline of over 10%.

2. On January 20, Morgan Stanley believed that Fosun Pharma's privatization of Hua Medicine would have a limited impact on it.

3. On January 20, the termination of the concerted action agreement by shareholders before the lock-up period raised market concerns, causing UBTECH's stock price to drop over 30%.

GameSquare is up 30.52% in pre-market trading. Based on recent important news:

1. On January 19, Anhui's leadership in the national biopharmaceutical alliance procurement led to a decline in stock prices of innovative drug companies, with Innovent Biologics experiencing the largest drop of over 10%.

2. On January 20, Morgan Stanley believed that the privatization event of Fosun Pharma would have a limited impact on the company.

3. On January 20, news of UBTECH shareholders reducing their holdings triggered a significant stock price drop of over 30%